Hennion & Walsh Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
208,766
-9,645
| -4% | -$13.8K | 0.01% | 817 |
|
|
2025
Q1 | $349K | Sell |
218,411
-8,736
| -4% | -$14K | 0.02% | 729 |
|
|
2024
Q4 | $818K | Buy |
227,147
+34,783
| +18% | +$125K | 0.04% | 513 |
|
|
2024
Q3 | $1.1M | Buy |
192,364
+49,532
| +35% | +$282K | 0.05% | 430 |
|
|
2024
Q2 | $660K | Buy |
+142,832
| New | +$660K | 0.03% | 517 |
|